Active Ingredient
Oxymetazoline hydrochloride, 0.05%
The following Structured Product Label (SPL) was submitted to the FDA by Samson Pharmaceuticals, Inc. for the product Breaze (NDC 20146-4000). This document serves as the official prescribing information, containing essential scientific data and clinical materials required for healthcare providers and patients.
This specific version of the label includes detailed information regarding active ingredient, purpose, uses, ask a doctor before use if you have, otc - do not use, otc - stop use, otc - pregnancy or breast feeding, otc - keep out of reach of children, and other regulatory disclosures. Use the navigation below to review specific sections of the FDA submission.
Oxymetazoline hydrochloride, 0.05%
Nasal Decongestant
Do not use more than directed
Stop use and ask a doctor if symptoms persist
If pregnant or breast- feeding, ask a health professional before use.
Keep out of reach of children. If swallowed, get medical help or contact a Poison Control Center right away.
Adult & children 6 to under 12 years of age (with adult supervision): 2 to 3 sprays in age nostril not more often than every 10 to 12 hours. Do not exceed 2 doses in any 24 –hr period.
Children under 6 years of age: ask a doctor. To spray, squeeze bottle quickly and firmly. Do not tilt head backward while spraying. Wipe nozzle clean after use.
Benzalkonium Chloride, Edetate Disodium, Glycerin, Polyethelene Glycol, Povidone, Propylene Glycol, Sodium Diphospahte Dibasic, Sodium Phosphate Monobasic, Water.
1-888-995-9935
Manufactured by:
Samson Pharmaceutical
Commerce, CA 90040
Made in USA
Visit our website at
www.samson.pharmaceutical.com
Made in USA
* Please review the disclaimer below.